HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes

Pediatric Diabetes

Volumn 12, Issue 4 PART 2, 2011, Pages 388-395

  Lipton, Rebecca B ^a   Drum, Melinda ^a   Greeley, Siri Atma W ^a   Danielson, Kirstie K ^a   Bell, Graeme I ^a   Hagopian, William A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

African Americans; Caucasians; Children and adolescents; Epidemiology; Ethnic differences; HLA DQA1 DQB1; Latinos; Phenotypes; T1DM; T2DM

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHILD; CHILDHOOD DISEASE; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GENETIC RISK; HAPLOTYPE; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AFRICAN AMERICANS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HISPANIC AMERICANS; HLA-DQ ANTIGENS; HUMANS; MALE;

EID: 79957480700     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00712.x     Document Type: Article

References (25)

1. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 1989: 338: 587-589.
2. Ikegami H, Kawabata Y, Noso S, Fujisawa T, Ogihara T. Genetics of type 1 diabetes in Asian and Caucasian populations. Diabetes Res Clin Pract 2007: 77 (Suppl. 1): S116-S121.
3. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009: 360: 1646-1654.
4. Cooper JD, Walker NM, Healy BC et al. Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1. Genes Immun 2009: 10 (Suppl. 1): S95-S120.
5. Bjørnvold M, Undlien DE, Joner G et al. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 2008: 51: 589-596.
6. Steck AK, Zhang W, Bugawan TL et al. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR, DQ genotypes?. Diabetes 2009: 58: 1028-1033.
7. Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM. IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes. J Natl Med Assoc 2004: 96: 1042-1046.
8. Soltesz G, Patterson CC, Dahlquist G; on behalf of EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence - what can we learn from epidemiology?. Pediatr Diabetes 2007: 8 (Suppl. 6): 6-14.
9. Smith TLS, Drum ML, Lipton RB. Incidence of childhood type 1 and non-type 1 diabetes in a diverse population: the Chicago Childhood Diabetes Registry, 1994 to 2003. J Pediatr Endocrinol Metab 2007: 20: 1093-1107.
10. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 2003: 26: 2876-2882.
11. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch Pediatr Adolesc Med 2006: 160: 523-528.
12. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997: 100: 84-91.
13. Urakami T, Kubota S, Nitadori Y, Harada K, Owada M, Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 2005: 28: 1876-1881.
14. Akinbami LJ, Saydah SH, Eberhardt MS, Polakowski LL. Racial disparities in diabetes mortality among persons aged 1-19 years - United States, 1979-2004. CDC Morb Mortal Wkly Rep 2007: 56: 1184-1187.
15. Lipton R, Good G, Mikhailov T, Freels S, Donoghue E. Ethnic differences in mortality from insulin-dependent diabetes mellitus among people less than 25 years of age. Pediatrics 1999: 103: 952-956.
16. Estrada CL, Danielson KK, Drum ML, Lipton RB. Hospitalization subsequent to diagnosis in young patients with diabetes in Chicago. Pediatrics 2009: 124: 926-934. PMID: 19706582.
17. Woo W, LaGasse JM, Zhou Z et al. A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies. J Immunol Meth 2000: 244: 91-103.
18. Sanjeevi CB, Hagopian WA, Landin-Olsson M et al. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens 1998: 51: 281-286.
19. Tsuji K, Aizawa M, Sasazuki T, eds. HLA. In: 11th international histocompatiblity workshop, Oxford, 1991.
20. Erlich H, Valdes AM, Noble J et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008: 57: 1084-1092.
21. Heward JM, Mijovic CH, Kelly MA, Morrison E, Barnett AH. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. Eur J Immunogenet 2002: 29: 47-52.
22. Faber OK, Binder C, Markussen J et al. Characterization of seven C-peptide antisera. Diabetes 1978: 27 (Suppl. 1): 170-177.
23. Berger B, Stenström G, Sundkvist G. Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest 2000: 60: 687-693.
24. Törn C, Landin-Olsson M, Lernmark A et al. Prognostic factors for the course of β-cell function in autoimmune diabetes. J Clin Endocrinol Metab 2000: 85: 4619-4623.
25. Antal Z, Jarchum I, DiLorenzo TP. HLA class I supertypes in type 1 diabetic children in an urban children's hospital. Ann N Y Acad Sci 2008: 1150: 86-89.